Renalytix plcRenalytix plcRenalytix plc

Renalytix plc

No trades
See on Supercharts
Market capitalization
‪41.67 M‬USD
−0.4659USD
‪−48.13 M‬USD
‪3.59 M‬USD
‪80.68 M‬
Beta (1Y)
2.37

About Renalytix plc

CEO
James Renwick McCullough
Headquarters
New York
Founded
2018
ISIN
GB00BYWL4Y04
FIGI
BBG00N2PY281
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RTNXF is 0.6212 USD — it has increased by 303.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Renalytix plc stocks are traded under the ticker RTNXF.
Renalytix plc is going to release the next earnings report on Jun 11, 2024. Keep track of upcoming events with our Earnings Calendar.
RTNXF stock is 78.38% volatile and has beta coefficient of 2.37. Check out the list of the most volatile stocks — is Renalytix plc there?
RTNXF earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.05 USD resulting in a −4.76% surprise. The estimated earnings for the next quarter are −0.05 USD per share. See more details about Renalytix plc earnings.
Renalytix plc revenue for the last quarter amounts to ‪459.00 K‬ USD despite the estimated figure of ‪715.00 K‬ USD. In the next quarter revenue is expected to reach ‪763.50 K‬ USD.
Yes, you can track Renalytix plc financials in yearly and quarterly reports right on TradingView.
RTNXF net income for the last quarter is ‪−8.71 M‬ USD, while the quarter before that showed ‪−9.79 M‬ USD of net income which accounts for 11.04% change. Track more Renalytix plc financial stats to get the full picture.
Today Renalytix plc has the market capitalization of ‪41.67 M‬, it has increased by 31.20% over the last week.
No, RTNXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RTNXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Renalytix plc stock right from TradingView charts — choose your broker and connect to your account.
RTNXF reached its all-time high on May 28, 2021 with the price of 17.1500 USD, and its all-time low was 0.1541 USD and was reached on Dec 13, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Renalytix plc technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Renalytix plc stock shows the sell signal. See more of Renalytix plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Renalytix plc future price: according to them, RTNXF price has a max estimate of 2.65 USD and a min estimate of 1.50 USD. Read a more detailed Renalytix plc forecast: see what analysts think of Renalytix plc and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Renalytix plc EBITDA is ‪−38.54 M‬ USD, and current EBITDA margin is ‪−1.23 K‬%. See more stats in Renalytix plc financial statements.